Welcome to the PREVAIL Trial

PREVenting infection using Antimicrobial Impregnated Long lines

PREVAIL is a Phase 3 Randomised Unblinded Trial, aiming to recruit 858 babies over 2 years, from 18 Neonatal Units across England.

The trial will determine the effectiveness and cost-effectiveness of antimicrobial impregnated Premicath catheters (Premistars) compared with standard Premicath for reducing Blood Stream Infection (BSI) in neonates.


I'm fine with this [X]

The site uses cookies, some may have been set already. Please refer to our privacy policy & cookie usage statement.
If you continue to use the site we'll assume you're happy to accept the cookies.